Flexible Abrocitinib Dosing Effective in Atopic Dermatitis

(MedPage Today) -- Abrocitinib, a once-daily oral Janus kinase 1 (JAK1) inhibitor, showed long-term efficacy at doses of 100 mg or 200 mg in patients with moderate-to-severe atopic dermatitis, according to a recent study presented at the American...